The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data

Author： Lichtenberg Frank R.

Publisher： American Economic Association

ISSN： 0002-8282

Source： The American Economic Review, Vol.97, Iss.2, 2007-05, pp. : 438-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001

By Lichtenberg Frank

International Journal of Health Care Finance and Economics, Vol. 5, Iss. 1, 2005-03 ,pp. : 47-73

Springer Publishing Company

Access to resources Recommend Favorite

The impact of new drug launches on the loss of labor from disease and injury: evidence from German panel data

By Bui Van Stolpe Michael

International Journal of Health Care Finance and Economics, Vol. 10, Iss. 4, 2010-12 ,pp. : 315-346

Springer Publishing Company

Access to resources Recommend Favorite

The determinants of health expenditures: evidence from US state-level data

By Wang Zijun

Applied Economics, Vol. 41, Iss. 4, 2009-02 ,pp. : 429-435

Routledge Ltd

Access to resources Recommend Favorite

Technological evolution as creative destruction of process heterogeneity: evidence from US plant-level data

By Essletzbichler Jürgen Rigby David

Economic Systems Research, Vol. 17, Iss. 1, 2005-03 ,pp. : 25-45

Routledge Ltd

Access to resources Recommend Favorite

The response of the US export prices to changes in the dollar's effective exchange rate: further evidence from industry level data

By Mahdavi Saeid

Applied Economics, Vol. 34, Iss. 17, 2002-11 ,pp. : 2115-2125

Routledge Ltd

Access to resources Recommend Favorite